Hennion & Walsh Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33,917	Closed	-$1.15M	–	778
2021 Q2	$1.15M	Buy	+33,917	New	+$864K	0.06%	333

Hennion & Walsh Asset Management's CNST Position: Q3 2021 in Review

Hennion & Walsh Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 33,917 shares — an estimated $1.15M sold.

Hennion & Walsh Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $1.15M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Hennion & Walsh Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Hennion & Walsh Asset Management sold 33,917 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.15M.
Hennion & Walsh Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Hennion & Walsh Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $1.15M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.